Cited by 34MRI in cancer diagnosisBreast Lesions and CarcinomasDigital Radiography and Breast Imaging

Breast MRI: False-Negative Results and Missed Opportunities.

Korhonen, Katrina E., Zuckerman, Samantha P., Weinstein, Susan P., Tobey, Jennifer, Birnbaum, Julia A., McDonald, Elizabeth S., Conant, Emily F.·2021·RadioGraphics

Abstract

Breast MRI is the most sensitive modality for the detection of breast cancer. However, false-negative cases may occur, in which the cancer is not visualized at MRI and is instead diagnosed with another imaging modality. The authors describe the causes of false-negative breast MRI results, which can be categorized broadly as secondary to perceptual errors or cognitive errors, or nonvisualization secondary to nonenhancement of the tumor. Tips and strategies to avoid these errors are discussed. Perceptual errors occur when an abnormality is not prospectively identified, yet the examination is technically adequate. Careful development of thorough search patterns is critical to avoid these errors. Cognitive errors occur when an abnormality is identified but misinterpreted or mischaracterized as benign. The radiologist may avoid these errors by utilizing all available prior examinations for comparison, viewing images in all planes to better assess the margins and shapes of abnormalities, and appropriately integrating all available information from the contrast-enhanced, T2-weighted, and T1-weighted images as well as the clinical history. Despite this, false-negative cases are inevitable, as certain subtypes of breast cancer, including ductal carcinoma in situ, invasive lobular carcinoma, and certain well-differentiated invasive cancers, may demonstrate little to no enhancement at MRI, owing to differences in angiogenesis and neovascularity. MRI is a valuable diagnostic tool in breast imaging. However, MRI should continue to be used as a complementary modality, with mammography and US, in the detection of breast cancer. ©RSNA, 2021

Integrity signals

Registry

Crossref · 10.1148/rg.2021200145

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Missing lesions smaller than 5 mm in early-stage tumor screening can have serious consequences for patient outcomes, as false negatives directly compromise diagnostic and therapeutic decisions.

    “in early-stage tumor screening, missing lesions smaller than 5 mmcan have serious consequences for patient outcomes, as false negatives directly compromise diagnostic and therapeutic decisions (Korhonen et al. 2021; Luo et al. 2023).”

    From Conformal Lesion Segmentation for 3D Medical Images (2025) · cites this paper as Korhonen et al. 2021

Cited by

Sorted by citations

Authors
Korhonen, K. E., Zuckerman, S. P., Weinstein, S. P., Tobey, J., Birnbaum, J. A., McDonald, E. S., & Conant, E. F.
Affiliations
Hospital of the University of Pennsylvania (US)
Venue
RadioGraphics
Published
2021-05
Volume
41
Issue
3
Pages
645-664
ISSN
  • 0271-5333 (ISSN-L)
  • 1527-1323
OpenAlex
W3136359523
Cited by
34
References
0
Citations by year
2026: 6 · 2025: 9 · 2024: 6 · 2023: 10 · 2022: 2 · 2021: 1
FWCI
2.51
Type
journal article
Language
en
Open access
closed
Locations
  • Radiographics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Digital Radiography and Breast Imaging
Keywords
breast MRI, false-negative results, breast cancer detection, perceptual errors, cognitive errors, search patterns, tumor enhancement, ductal carcinoma in situ, invasive lobular carcinoma, angiogenesis, neovascularization, mammography, breast ultrasound
MeSH terms
Breast, Breast Neoplasms, Female, Humans, Magnetic Resonance Imaging, Mammography, Sensitivity and Specificity, Carcinoma, Ductal, Breast

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review